{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:30:47Z","timestamp":1784172647538,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K15577"],"award-info":[{"award-number":["JP18K15577"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.phro.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T13:34:28Z","timestamp":1633786468000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"Takaaki","family":"Yoshimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouki","family":"Kogame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodai","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kanehira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishin","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeko","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phro.2021.09.006_b0005","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-015-0522-5","article-title":"Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer","volume":"10","author":"Yeo","year":"2015","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.phro.2021.09.006_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-016-0761-0","article-title":"Treatment planning comparison of IMPT, VMAT and 4\u03c0 radiotherapy for prostate cases","volume":"12","author":"Tran","year":"2017","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.phro.2021.09.006_b0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijrobp.2010.05.027","article-title":"Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities","volume":"81","author":"Nihei","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1054","key":"10.1016\/j.phro.2021.09.006_b0020","doi-asserted-by":"crossref","first-page":"20140736","DOI":"10.1259\/bjr.20140736","article-title":"Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer","volume":"88","author":"Ruggieri","year":"2015","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.phro.2021.09.006_b0025","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/j.ijrobp.2012.03.028","article-title":"Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study","volume":"84","author":"Weber","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.phro.2021.09.006_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-7-82","article-title":"Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy","volume":"7","author":"Vainshtein","year":"2012","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.phro.2021.09.006_b0035","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2020.06.002","article-title":"Urethra-sparing stereotactic body radiation therapy for prostate cancer: quality assurance of a randomized phase 2 trial","volume":"108","author":"Jaccard","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.phro.2021.09.006_b0040","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-9-118","article-title":"Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system","volume":"9","author":"Shimizu","year":"2014","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.phro.2021.09.006_b0045","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2010.07.1978","article-title":"Analysis of prostate patient setup and tracking data: potential intervention strategies","volume":"81","author":"Su","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.phro.2021.09.006_b0050","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1088\/0031-9155\/53\/4\/014","article-title":"Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties","volume":"53","author":"Lomax","year":"2008","journal-title":"Phys Med Biol"},{"issue":"4","key":"10.1016\/j.phro.2021.09.006_b0055","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1088\/0031-9155\/53\/4\/015","article-title":"Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions","volume":"53","author":"Lomax","year":"2008","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1016\/j.phro.2021.09.006_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-019-1424-8","article-title":"The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapy","volume":"14","author":"Dekura","year":"2019","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.phro.2021.09.006_b0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.radonc.2011.11.015","article-title":"Urethra sparing - potential of combined Nickel-Titanium stent and intensity modulated radiation therapy in prostate cancer","volume":"103","author":"Thomsen","year":"2012","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.phro.2021.09.006_b0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/acm2.12804","article-title":"Analysis of treatment process time for real-time-image gated-spot-scanning proton-beam therapy (RGPT) system","volume":"21","author":"Yoshimura","year":"2020","journal-title":"J Appl Clin Med Phys"},{"issue":"12","key":"10.1016\/j.phro.2021.09.006_b0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/acm2.13029","article-title":"Quantitative analysis of treatments using real-time image gated spot-scanning with synchrotron-based proton beam therapy system log data","volume":"21","author":"Yoshimura","year":"2020","journal-title":"J Appl Clin Med Phys"},{"issue":"5","key":"10.1016\/j.phro.2021.09.006_b0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ejmp.2014.04.002","article-title":"Preliminary analysis for integration of spot-scanning proton beam therapy and real-time imaging and gating","volume":"30","author":"Shimizu","year":"2014","journal-title":"Phys Med"},{"issue":"4","key":"10.1016\/j.phro.2021.09.006_b0085","doi-asserted-by":"crossref","first-page":"e94971","DOI":"10.1371\/journal.pone.0094971","article-title":"A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size","volume":"9","author":"Shimizu","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.phro.2021.09.006_b0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.phro.2021.09.006_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phro.2021.03.002","article-title":"Visualizing the urethra by magnetic resonance imaging without usage of a catheter for radiotherapy of prostate cancer","volume":"18","author":"Yoshimura","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"6","key":"10.1016\/j.phro.2021.09.006_b0100","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.prro.2018.08.002","article-title":"Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guideline","volume":"8","author":"Morgan","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.phro.2021.09.006_b0105","series-title":"JASTRO Guidelines 2020 for Radiotherapy Treatment Planning","author":"Shigematsu","year":"2020"},{"issue":"4","key":"10.1016\/j.phro.2021.09.006_b0110","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/j.ijrobp.2011.04.043","article-title":"Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion","volume":"81","author":"Shimizu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2021.09.006_b0115","doi-asserted-by":"crossref","unstructured":"Umezawa M, Fujimoto R, Umekawa T, Fujii Y, Takayanagi T, Ebina F, et al. Development of the compact proton beam therapy system dedicated to spot scanning with real-time tumor-tracking technology. Melville, NY: AIP Publishing; 2013. https:\/\/doi.org\/10.1063\/1.4802351.","DOI":"10.1063\/1.4802351"},{"issue":"9","key":"10.1016\/j.phro.2021.09.006_b0120","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1118\/1.4745558","article-title":"Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation study","volume":"39","author":"Matsuura","year":"2012","journal-title":"Med Phys"},{"issue":"9","key":"10.1016\/j.phro.2021.09.006_b0125","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ejmp.2016.08.007","article-title":"NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies - A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT)","volume":"32","author":"Yoshimura","year":"2016","journal-title":"Phys Med"},{"issue":"11","key":"10.1016\/j.phro.2021.09.006_b0130","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2021.09.006_b0135","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2307\/3583506","article-title":"Complication probability as assessed from dose-volume histograms","volume":"8","author":"Lyman","year":"1985","journal-title":"Radiat Res Suppl"},{"key":"10.1016\/j.phro.2021.09.006_b0140","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","article-title":"Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method","volume":"16","author":"Kutcher","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.phro.2021.09.006_b0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: a concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"issue":"3-4","key":"10.1016\/j.phro.2021.09.006_b0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejmp.2007.07.001","article-title":"A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy","volume":"23","author":"Gay","year":"2007","journal-title":"Phys Med"},{"issue":"5","key":"10.1016\/j.phro.2021.09.006_b0155","doi-asserted-by":"crossref","first-page":"051708","DOI":"10.1118\/1.4801897","article-title":"Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions","volume":"40","author":"Zeng","year":"2013","journal-title":"Med Phys"},{"issue":"8","key":"10.1016\/j.phro.2021.09.006_b0160","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1088\/1361-6560\/62\/8\/3003","article-title":"MRI micturating urethrography for improved urethral delineation in prostate radiotherapy planning: a case study","volume":"62","author":"Rai","year":"2017","journal-title":"Phys Med Biol"},{"issue":"6","key":"10.1016\/j.phro.2021.09.006_b0165","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/j.prro.2019.06.009","article-title":"Comparison of motion-insensitive T2-weighted mri pulse sequences for visualization of the prostatic urethra during MR simulation","volume":"9","author":"Zakian","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"9","key":"10.1016\/j.phro.2021.09.006_b0170","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1118\/1.3481514","article-title":"Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models","volume":"37","author":"Takam","year":"2010","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.phro.2021.09.006_b0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijrobp.2020.01.010","article-title":"Diminishing returns from ultrahypofractionated radiation therapy for prostate cancer","volume":"107","author":"Vogelius","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.phro.2021.09.006_b0180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2007.03.018","article-title":"Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison","volume":"69","author":"Trofimov","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2021.09.006_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.652678","article-title":"Influence of urethra sparing on tumor control probability and normal tissue complication probability in focal dose escalated hypofractionated radiotherapy: a planning study based on histopathology reference","volume":"11","author":"Spohn","year":"2021","journal-title":"Front Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631621000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631621000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:13:29Z","timestamp":1762503209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631621000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":37,"alternative-id":["S2405631621000567"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2021.09.006","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}]}}